ACADIA Pharmaceuticals Inc.
NASDAQ:ACAD
17.66 (USD) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 726.437 | 517.235 | 484.145 | 441.755 | 339.076 | 223.807 | 124.901 | 17.331 | 0.061 | 0.12 | 1.145 | 4.907 | 2.067 | 42.135 | 6.399 | 1.59 | 7.555 | 8.133 | 10.956 | 4.604 | 7.378 | 6.276 | 3.714 | 4.312 |
| Cost of Revenue
| 45.731 | 10.166 | 19.141 | 20.55 | 19.598 | 18.33 | 13.06 | 4.406 | 76.369 | 60.602 | 26.722 | 18.794 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 680.706 | 507.069 | 465.004 | 421.205 | 319.478 | 205.477 | 111.841 | 12.925 | -76.308 | -60.482 | -25.577 | -13.887 | 2.067 | 42.135 | 6.399 | 1.59 | 7.555 | 8.133 | 10.956 | 4.604 | 7.378 | 6.276 | 3.714 | 4.312 |
| Gross Profit Ratio
| 0.937 | 0.98 | 0.96 | 0.953 | 0.942 | 0.918 | 0.895 | 0.746 | -1,250.951 | -504.017 | -22.338 | -2.83 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Reseach & Development Expenses
| 351.619 | 361.575 | 239.415 | 319.13 | 240.385 | 187.163 | 149.189 | 99.284 | 73.869 | 60.602 | 26.722 | 18.794 | 17.309 | 20.579 | 41.585 | 56.75 | 57.942 | 49.398 | 30.848 | 23.454 | 16.935 | 14.921 | 13.09 | 9.728 |
| General & Administrative Expenses
| 393.066 | 363.59 | 396.028 | 388.661 | 325.638 | 265.758 | 255.062 | 186.456 | 90.804 | 32.748 | 12.72 | 6.999 | 7.61 | 6.462 | 10.282 | 11.818 | 12.267 | 11.349 | 15.915 | 7.246 | 4.183 | 3.981 | 3.756 | 2.999 |
| Selling & Marketing Expenses
| 9.4 | 5.5 | 41.8 | 51.1 | 38.3 | 39.8 | 15.6 | 1.6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 402.466 | 369.09 | 396.028 | 388.661 | 325.638 | 265.758 | 255.062 | 186.456 | 90.804 | 32.748 | 12.72 | 6.999 | 7.61 | 6.462 | 10.282 | 11.818 | 12.267 | 11.349 | 15.915 | 7.246 | 4.183 | 3.981 | 3.756 | 2.999 |
| Other Expenses
| 5.109 | 3.542 | 2.329 | -0.997 | 0.997 | -1.84 | 3.983 | 1.331 | 2.5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3.56 | 7.528 | 2.356 | 0 | 0 | 2.147 | 2.854 |
| Operating Expenses
| 754.085 | 730.665 | 635.443 | 707.791 | 566.023 | 452.921 | 404.251 | 285.74 | 164.673 | 93.35 | 39.442 | 25.793 | 24.919 | 27.041 | 51.867 | 68.568 | 70.209 | 57.187 | 46.763 | 30.7 | 21.118 | 18.902 | 18.993 | 15.581 |
| Operating Income
| -73.379 | -223.596 | -170.439 | -286.586 | -246.545 | -247.444 | -292.41 | -272.815 | -164.612 | -93.23 | -38.297 | -20.886 | -22.852 | 15.094 | -45.468 | -66.978 | -62.654 | -49.054 | -35.806 | -26.095 | -13.74 | -12.626 | -15.279 | -11.269 |
| Operating Income Ratio
| -0.101 | -0.432 | -0.352 | -0.649 | -0.727 | -1.106 | -2.341 | -15.741 | -2,698.557 | -776.917 | -33.447 | -4.256 | -11.056 | 0.358 | -7.105 | -42.125 | -8.293 | -6.031 | -3.268 | -5.668 | -1.862 | -2.012 | -4.114 | -2.613 |
| Total Other Income Expenses Net
| 22.343 | 10.152 | 2.92 | 5.613 | 12.162 | -1.84 | 4.126 | 2.763 | 0.499 | 0.755 | 0.349 | 0.037 | 0.087 | 0.045 | 0.323 | 2.734 | 6.264 | 3.56 | 1.671 | 0.178 | 0 | 0 | 0 | 0 |
| Income Before Tax
| -51.036 | -213.444 | -167.519 | -280.973 | -234.383 | -243.936 | -288.284 | -270.052 | -164.113 | -92.475 | -37.948 | -20.849 | -22.765 | 15.139 | -45.145 | -64.244 | -56.39 | -45.048 | -34.135 | -25.917 | 0 | 0 | 0 | 0 |
| Income Before Tax Ratio
| -0.07 | -0.413 | -0.346 | -0.636 | -0.691 | -1.09 | -2.308 | -15.582 | -2,690.377 | -770.625 | -33.142 | -4.249 | -11.014 | 0.359 | -7.055 | -40.405 | -7.464 | -5.539 | -3.116 | -5.629 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 10.25 | 2.531 | 0.351 | 0.611 | 0.876 | 1.256 | 1.119 | 1.341 | 0.33 | -0.206 | 0 | -0.109 | 0 | 0 | 0 | -1.043 | 0 | -3.86 | -0 | -0 | 0.353 | 0.242 | 14.406 | 10.194 |
| Net Income
| -61.286 | -215.975 | -167.87 | -281.584 | -235.259 | -245.192 | -289.403 | -271.393 | -164.443 | -92.475 | -37.948 | -20.849 | -22.765 | 15.139 | -45.145 | -64.244 | -56.39 | -45.048 | -34.135 | -25.917 | -14.093 | -12.868 | -14.406 | -10.194 |
| Net Income Ratio
| -0.084 | -0.418 | -0.347 | -0.637 | -0.694 | -1.096 | -2.317 | -15.659 | -2,695.787 | -770.625 | -33.142 | -4.249 | -11.014 | 0.359 | -7.055 | -40.405 | -7.464 | -5.539 | -3.116 | -5.629 | -1.91 | -2.051 | -3.879 | -2.364 |
| EPS
| -0.37 | -1.34 | -1.05 | -1.79 | -1.6 | -1.94 | -2.36 | -2.34 | -1.63 | -0.95 | -0.44 | -0.38 | -0.44 | 0.39 | -1.2 | -1.73 | -1.6 | -1.61 | -1.55 | -2.5 | -9.66 | -8.86 | -11.93 | -9.53 |
| EPS Diluted
| -0.37 | -1.34 | -1.05 | -1.79 | -1.6 | -1.94 | -2.36 | -2.34 | -1.63 | -0.95 | -0.44 | -0.38 | -0.44 | 0.39 | -1.2 | -1.73 | -1.6 | -1.61 | -1.55 | -2.5 | -1.24 | -8.86 | -11.93 | -9.53 |
| EBITDA
| -67.827 | -223.596 | -170.439 | -286.586 | -246.545 | -247.444 | -292.41 | -272.815 | -164.612 | -93.23 | -38.218 | -20.886 | -22.567 | 15.701 | -44.357 | -66.978 | -61.886 | -52.614 | -34.781 | -24.79 | -12.396 | -11.223 | -15.279 | -11.269 |
| EBITDA Ratio
| -0.093 | -0.432 | -0.352 | -0.649 | -0.727 | -1.106 | -2.341 | -15.741 | -2,698.557 | -776.917 | -33.378 | -4.256 | -10.918 | 0.373 | -6.932 | -42.125 | -8.191 | -6.469 | -3.174 | -5.384 | -1.68 | -1.788 | -4.114 | -2.613 |